HIV-1 virion fusion assay: Uncoating not required and no effect of Nef on fusion

Virology

Volumn 328, Issue 1, 2004, Pages 36-44

  Cavrois, Marielle ^a   Neidleman, Jason ^a   Yonemoto, Wes ^a   Fenard, David ^a   Greene, Warner C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fusion; HIV 1; Infectivity; Nef; Primary cells; Uncoating; Virions

Indexed keywords

ACTIN; CD4 ANTIGEN; NEF PROTEIN;

ARTICLE; ASSAY; CELL FUSION; CELL MEMBRANE; CELL STRAIN; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; VIRION; VIRUS CORE; VIRUS INFECTIVITY; VIRUS PARTICLE; WILD TYPE;

BETA-LACTAMASES; BETA-LACTAMS; CELL LINE; CYTOPLASM; FLUORESCEINS; GENE PRODUCTS, NEF; GENE PRODUCTS, VPR; HIV CORE PROTEIN P24; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; LACTAMS; MEMBRANE FUSION; SUBSTRATE SPECIFICITY; VIRULENCE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 4544240500     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.07.015     Document Type: Article

References (40)

1. C. Aiken Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A J. Virol. 71 1997 5871 5877
2. C. Aiken, and D. Trono Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis J. Virol. 69 1995 5048 5056
3. V.K. Arora, B.L. Fredericksen, and J.V. Garcia Nef: agent of cell subversion Microbes Infect. 4 2002 189 199
4. E.A. Berger, P.M. Murphy, and J.M. Farber Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease Annu. Rev. Immunol. 17 1999 657 700
5. A.A. Bukovsky, T. Dorfman, A. Weimann, and H.G. Gottlinger Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease J. Virol. 71 1997 1013 1018
6. E.M. Campbell, and T.J. Hope The infectivity enhancement of HIV-1 Nef involves the actin cytosqueleton J. Virol. 11 2004 5745 5755
7. C. Cartier, P. Sivard, C. Tranchat, D. Decimo, C. Desgranges, and V. Boyer Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection J. Biol. Chem. 274 1999 19434 19440
8. C. Cartier, B. Hemonnot, B. Gay, M. Bardy, C. Sanchiz, C. Devaux, and L. Briant Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein J. Biol. Chem. 278 2003 35211 35219
9. M. Cavrois, C. De Noronha, and W.C. Greene A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes Nat. Biotechnol. 20 2002 1151 1154
10. M. Cavrois, J. Neidleman, M. Bigos, and W.C. Greene Fluorescence resonance energy transfer-based HIV-1 virion fusion assay Methods Mol. Biol. 263 2004 333 344
11. N. Chazal, G. Singer, C. Aiken, M.L. Hammarskjold, and D. Rekosh Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity J. Virol. 75 2001 4014 4018
12. M.Y. Chowers, M.W. Pandori, C.A. Spina, D.D. Richman, and J.C. Guatelli The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation Virology 212 1995 451 457
13. J.R. Day, C. Munk, and J.C. Guatelli The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity J. Virol. 78 2004 1069 1079
14. B.M. Forshey, and C. Aiken Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein complex J. Virol. 77 2003 4409 4414
15. E.K. Franke, H.E. Yuan, and J. Luban Specific incorporation of cyclophilin A into HIV-1 virions Nature 372 1994 359 362
16. M.K. Gorny, V. Gianakakos, S. Sharpe, and S. Zolla-Pazner Generation of human monoclonal antibodies to human immunodeficiency virus Proc. Natl. Acad. Sci. U.S.A. 86 1989 1624 1628
17. W.C. Greene, and B.M. Peterlin Charting HIV's remarkable voyage through the cell: basic science as a passport to future therapy Nat. Med. 8 2002 673 680
18. Y. Jenkins, M. McEntee, K. Weis, and W.C. Greene Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways J. Cell Biol. 143 1998 875 885
19. M. Khan, M. Garcia-Barrio, and M.D. Powell Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription J. Virol. 75 2001 12081 12087
20. J. Lama, A. Mangasarian, and D. Trono Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner Curr. Biol. 9 1999 622 631
21. T. Luo, J.L. Douglas, R.L. Livingston, and J.V. Garcia Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems Virology 241 1998 224 233
22. M.D. Miller, M.T. Warmerdam, I. Gaston, W.C. Greene, and M.B. Feinberg The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages J. Exp. Med. 179 1994 101 113
23. M.D. Miller, M.T. Warmerdam, K.A. Page, M.B. Feinberg, and W.C. Greene Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry J. Virol. 69 1995 579 584
24. M.D. Miller, M.T. Warmerdam, S.S. Ferrell, R. Benitez, and W.C. Greene Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity Virology 234 1997 215 225
25. W. Paxton, R.I. Connor, and N.R. Landau Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis J. Virol. 67 1993 7229 7237
26. V. Piguet, and D. Trono The Nef protein of primate lentiviruses Rev. Med. Virol. 9 1999 111 120
27. S.S. Rawat, M. Viard, S.A. Gallo, A. Rein, R. Blumenthal, and A. Puri Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review) Mol. Membr. Biol. 20 2003 243 254
28. V.I. Razinkov, and F.S. Cohen Sterols and sphingolipids strongly affect the growth of fusion pores induced by the hemagglutinin of influenza virus Biochemistry 39 2000 13462 13468
29. T.M. Ross, A.E. Oran, and B.R. Cullen Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein Curr. Biol. 9 1999 613 621
30. E. Schaeffer, R. Geleziunas, and W.C. Greene Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions J. Virol. 75 2001 2993 3000
31. O. Schwartz, V. Marechal, O. Danos, and J.M. Heard Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell J. Virol. 69 1995 4053 4059
32. C.A. Spina, T.J. Kwoh, M.Y. Chowers, J.C. Guatelli, and D.D. Richman The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes J. Exp. Med. 179 1994 115 123
33. A.M. Szilvay, S. Nornes, I.R. Haugan, L. Olsen, V.R. Prasad, C. Endresen, S.P. Goff, and D.E. Helland Epitope mapping of HIV-1 reverse transcriptase with monoclonal antibodies that inhibit polymerase and RNase H activities J. Acquired Immune Defic. Syndr. 5 1992 647 657
34. M. Tobiume, K. Tokunaga, E. Kiyokawa, M. Takahoko, N. Mochizuki, M. Tatsumi, and M. Matsuda Requirement of nef for HIV-1 infectivity is biased by the expression levels of Env in the virus-producing cells and CD4 in the target cells Arch. Virol. 146 2001 1739 1751
35. M. Tobiume, J.E. Lineberger, C.A. Lundquist, M.D. Miller, and C. Aiken Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells J. Virol. 77 2003 10645 10650
36. R. Welker, H. Kottler, H.R. Kalbitzer, and H.G. Krausslich Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase Virology 219 1996 228 236
37. R. Welker, H. Hohenberg, U. Tessmer, C. Huckhagel, and H.G. Krausslich Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1 J. Virol. 74 2000 1168 1177
38. Y.H. Zheng, A. Plemenitas, T. Linnemann, O.T. Fackler, and B.M. Peterlin Nef increases infectivity of HIV via lipid rafts Curr. Biol. 11 2001 875 879
39. Y.H. Zheng, A. Plemenitas, C.J. Fielding, and B.M. Peterlin Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions Proc. Natl. Acad. Sci. U.S.A. 100 2003 8460 8465
40. G. Zlokarnik, P.A. Negulescu, T.E. Knapp, L. Mere, N. Burres, L. Feng, M. Whitney, K. Roemer, and R.Y. Tsien Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter Science 279 1998 84 88